ReviewImmunological reviews2014

A new approach to gene therapy using Sleeping Beauty to genetically modify clinical-grade T cells to target CD19.

Harjeet Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.